✦ LIBER ✦

Cytotoxic activity of topoisomerase II inhibitors in primary cultures of tumor cells from patients with human hematologic and solid tumors

✍ Scribed by Rolf Larsson; Peter Nygren

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 569 KB
Volume: 74
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19941115)74:10<2857::aid-cncr2820741019>3.0.co;2-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Detection of tumor-specific cytotoxic dr

Detection of tumor-specific cytotoxic drug activity IN VITRO using the fluorometric microculture cytotoxicity assay and primary cultures of tumor cells from patients

✍ Peter Nygren; Helena Fridborg; Katalin Csoka; Christer Sundström; Manuel De La T 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 904 KB

The semi-automated fluorometric microculture cytotoxicity assay (FMCA), based on the measurement of fluorescence generated from cellular hydrolysis of fluorescein diacetate (FDA) by viable cells, was employed for cytotoxic drug sensitivity testing of tumor cells from patients with hematological or s

Selective sensitivity of solid tumors to

Selective sensitivity of solid tumors to suramin in primary cultures of tumor cells from patients

✍ Katalin Csoka; Peter Nygren; Wilhelm Graf; Lars Påhlman; Bengt Glimelius; Rolf L 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 571 KB

The antineoplastic activity of suramin is currently the subject of clinical trials. We therefore used the semi-automated fluorometric microculture cytotoxicity assay (FMCA) to evaluate the cytotoxicity of suramin in vitro in primary cultures of cells from patients with hematological or solid tumors.

CD80 expression in an HLA-A2-positive hu

CD80 expression in an HLA-A2-positive human non-small cell lung cancer cell line enhances tumor-specific cytotoxicity of HLA-A2-positive T cells derived from a normal donor and a patient with non-small cell lung cancer

✍ Dale L. Bixby; John R. Yannelli 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 185 KB 👁 2 views

To generate non-small cell lung cancer (NSCLC)-reactive lymphocytes, we transfected an HLA-A2-expressing human NSCLC line (1355) with the cDNA encoding the lymphocyte co-stimulatory molecule CD80. Following selection in G418, 1355.7 demonstrated stable cell-surface expression of CD80. Allogeneic mix